We’re excited to be attending EUROTOX 2025, taking place in Athens, Greece, from 14–17 September. This year’s theme, “Toxicology addresses society’s real-life risks for sustainable health and well-being,” highlights the crucial role of science and technology in building a healthier, more sustainable future.
In line with this theme, Lhasa will be actively contributing to the scientific programme with a range of expert-led sessions and presentations:
Monday 15 September | 10:00 – 12:00
Carcinogenicity testing after the ICH S1B revision – where are we now?
Lhasa Principal Scientist Dr Susanne Stalford will co-chair this session, which explores the evolving landscape of carcinogenicity testing. Susanne will present on the role of in silico decision support systems in enabling next-generation risk assessment for carcinogenicity.
Monday 15 September | 12:00 – 13:00
Integrating in silico approaches for genotoxicity risk assessment
Join Principal Scientist Dr Robert Foster and Senior Application Scientist Toni Rogers as they lead this Lhasa-hosted session focused on the practical application of in silico tools in genotoxicity assessment. Tailored for professionals in the pharmaceutical and agrochemical industries, this session will cover regulatory expectations, share real-world case studies, and demonstrate how in silico approaches can support confident impurity and pesticide residue evaluation.
Monday 15 September / Tuesday 16 September
What does new nitrosamine data reveal about the CPCA framework?
This poster, presented by Ben Thornton, Lhasa Scientist, explores recent data insights on nitrosamine impurities and their impact on the Carcinogenic Potency Categorisation Approach (CPCA) – a key regulatory framework for nitrosamine risk assessment.
Drawing on over 328 nitrosamines from Lhasa’s Vitic chemical database and Carcinogenicity Database (LCDB), this analysis uses structural clustering and expert review to identify structure-activity relationships (SARs) associated with non-mutagenicity. This work complements the mechanistic basis of current regulatory frameworks and highlights the evolving scientific understanding that can help refine CPCA and improve its predictive accuracy.
You can find us at booth A61 throughout the conference.
We look forward to connecting with fellow scientists and sharing how Lhasa’s collaborative, science-led solutions are shaping the future of chemical safety assessment.